GO:1901082 positive regulation of relaxation of smooth muscle: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901082 describes any process that activates or increases the frequency, rate or extent of smooth muscle relaxation, a biological process ontology term.
• Smooth muscle relaxation is driven by reduced intracellular Ca2+ and decreased myosin light chain kinase activity, often through cyclic nucleotide signaling.
• Adrenergic receptors and catecholamines are major positive regulators of smooth muscle relaxation in cardiovascular and other tissues.
• Calcium sparks and large-conductance Ca2+-activated K+ (BK) channels, encoded by KCNMA1 and KCNMB1, are key negative feedback regulators that promote relaxation.
• Purinergic inhibitory nerve transmission and PDGFRα-positive cells contribute to positive regulation of smooth muscle relaxation in the gut.
• Dysregulation of smooth muscle relaxation is linked to hypertension, asthma, gastrointestinal motility disorders, and radiotherapy-induced rectal dysfunction.
Description
GO:1901082, positive regulation of relaxation of smooth muscle, is a Gene Ontology biological process term that encompasses any process that activates or increases the frequency, rate or extent of smooth muscle relaxation. Smooth muscle relaxation is essential for normal physiology, including vasodilation, bronchial dilation, gastrointestinal motility, and bladder emptying. The term is distinct from the general relaxation of smooth muscle (GO:0044557) because it specifically covers upstream activating signals, such as adrenergic stimulation, cyclic nucleotide elevation, and ion channel modulation. Researchers study this process to understand how tissues dynamically adjust contractile tone in response to neural, hormonal, and local metabolic cues. Defects in positive regulation of smooth muscle relaxation contribute to major human diseases, including hypertension, asthma, and gastrointestinal dysmotility. Therefore, identifying the genes and signaling pathways that positively regulate smooth muscle relaxation is critical for developing targeted therapies.
positive regulation of relaxation of smooth muscle At A Glance
| GO ID | GO:1901082 |
|---|---|
| GO term | positive regulation of relaxation of smooth muscle |
| Ontology | biological_process |
| Synonym | activation of relaxation of smooth muscle; activation of smooth muscle relaxation; positive regulation of smooth muscle relaxation; up regulation of relaxation of smooth muscle; up-regulation of relaxation of smooth muscle; upregulation of relaxation of smooth muscle; up regulation of smooth muscle relaxation; up-regulation of smooth muscle relaxation; upregulation of smooth muscle relaxation |
| Major function | Activates or increases the frequency, rate or extent of smooth muscle relaxation |
| Related process | Relaxation of smooth muscle (GO:0044557) |
| Key regulators | Adrenergic receptors, cyclic nucleotides, BK channels, purinergic signaling |
| Disease relevance | Hypertension, asthma, gastrointestinal dysmotility, radiotherapy-induced dysfunction |
What Is GO:1901082?
According to the Gene Ontology, GO:1901082 is defined as any process that activates or increases the frequency, rate or extent of relaxation of smooth muscle. In other words, it covers the molecular events that turn on or enhance the relaxation of smooth muscle cells, as opposed to the relaxation process itself. This includes receptor-mediated signaling, second messenger production, ion channel activity, and phosphatase regulation that collectively reduce contractile force.
Why Is positive regulation of relaxation of smooth muscle Important in Cell Biology?
Positive regulation of smooth muscle relaxation is fundamental to cardiovascular, respiratory, gastrointestinal, and urogenital physiology. It controls blood pressure by regulating vascular tone, airway diameter by controlling bronchial smooth muscle, and gut motility by modulating peristalsis. Pharmacological agents that enhance smooth muscle relaxation, such as beta-adrenergic agonists and nitric oxide donors, are mainstays for treating asthma, hypertension, and erectile dysfunction. Conversely, impaired relaxation contributes to diseases like hypertension, asthma, and diabetic gastroparesis. Understanding the molecular players in GO:1901082 provides a rational basis for drug discovery and for interpreting genetic variants associated with smooth muscle disorders.
• Regulates vascular tone and blood pressure; dysfunction leads to hypertension.
• Controls airway diameter; impaired relaxation contributes to asthma and COPD.
• Modulates gastrointestinal motility; abnormal relaxation causes dysmotility and constipation.
• Involved in bladder function; defects lead to overactive bladder or urinary retention.
• Mediates penile erection; positive regulators are targets for erectile dysfunction drugs.
• Plays a role in uterine relaxation during pregnancy; dysregulation may contribute to preterm labor.
• Affected by radiotherapy in rectal smooth muscle, reducing ATP-mediated relaxation.
• Key for understanding smooth muscle phenotypic switch in vascular disease.
• Provides targets for bronchodilators, vasodilators, and gastrointestinal prokinetics.
• Central to the study of purinergic inhibitory neurotransmission.
What Happens During positive regulation of relaxation of smooth muscle?
Initiation by Neurotransmitters and Hormones
In simple terms: Signals from nerves or hormones tell the muscle to relax.
Positive regulation of smooth muscle relaxation often begins with the release of neurotransmitters or hormones that bind to G protein-coupled receptors on smooth muscle cells. For example, catecholamines such as epinephrine and norepinephrine activate beta-adrenergic receptors, which stimulate Gs proteins and increase cyclic AMP (cAMP) levels. In the gastrointestinal tract, purinergic inhibitory nerves release ATP, which acts on P2Y receptors on PDGFRα-positive cells to promote relaxation. These initial signals set off a cascade that reduces intracellular calcium and decreases contractile machinery activity.
Second Messenger Production and Protein Kinase Activation
In simple terms: Inside the cell, molecules like cAMP and cGMP are made, which activate enzymes that promote relaxation.
Activation of adenylyl cyclase or guanylyl cyclase produces cAMP or cGMP, respectively. These cyclic nucleotides activate protein kinase A (PKA) or protein kinase G (PKG), which phosphorylate multiple targets. PKA and PKG reduce the sensitivity of the contractile apparatus to calcium by phosphorylating myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) regulators. This leads to decreased myosin light chain phosphorylation and thus relaxation. The role of cyclic nucleotides is well established, although some studies show that certain relaxants, like MBCQ, may act independently of cyclic nucleotide regulation in specific tissues.
Calcium Handling and Ion Channel Modulation
In simple terms: Calcium levels inside the cell drop, and potassium channels open to help the muscle relax.
A key step in smooth muscle relaxation is the reduction of intracellular Ca2+ concentration. This occurs through inhibition of voltage-gated Ca2+ channels, activation of Ca2+ pumps and exchangers, and sequestration of Ca2+ into the sarcoplasmic reticulum. Calcium sparks, local transient increases in Ca2+ near the sarcoplasmic reticulum, activate large-conductance Ca2+-activated K+ (BK) channels, leading to membrane hyperpolarization and relaxation. The BK channel is composed of a pore-forming alpha subunit (KCNMA1) and regulatory beta subunits such as KCNMB1. Reduced expression of KCNMB1 has been linked to vascular smooth muscle cell phenotypic switch and apoptosis, highlighting its importance in maintaining a relaxed, contractile phenotype.
Modulation by Polyamines and Phosphatases
In simple terms: Other molecules like polyamines can fine-tune calcium channels and phosphatases to influence relaxation.
Polyamines, such as spermine and spermidine, regulate Ca2+ channel and phosphatase activities in intestinal and vascular smooth muscle, with implications for cellular growth and contractility. They can modulate the activity of protein phosphatases, including MLCP, which dephosphorylates myosin light chains to promote relaxation. This adds another layer of regulation to the positive regulation of smooth muscle relaxation, linking metabolic state to contractile tone.
Integration with Cellular Phenotype and Disease
In simple terms: Long-term changes in relaxation pathways can alter smooth muscle cell identity and contribute to disease.
Chronic alterations in positive regulation of relaxation can lead to phenotypic switching of smooth muscle cells, as seen in vascular diseases where reduced KCNMB1 expression promotes a synthetic, pro-apoptotic phenotype. Additionally, conditions like radiotherapy can impair ATP-mediated relaxation in human rectal smooth muscle, demonstrating that external stressors can disrupt these pathways. Thus, the process is not only acute but also influences long-term tissue remodeling and disease progression.
Key Genes Involved in GO:1901082 positive regulation of relaxation of smooth muscle
The following genes and proteins are central to the positive regulation of smooth muscle relaxation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB2 | Beta-2 adrenergic receptor; mediates catecholamine-induced relaxation | Target for asthma and hypertension drugs |
| ADRB1 | Beta-1 adrenergic receptor; contributes to cardiac and vascular relaxation | Studied for cardiovascular effects of catecholamines |
| KCNMA1 | Pore-forming alpha subunit of BK channel; mediates calcium spark-induced hyperpolarization | Key regulator of vascular and airway tone |
| KCNMB1 | Regulatory beta-1 subunit of BK channel; modulates channel calcium sensitivity | Reduced expression linked to vascular smooth muscle phenotypic switch |
| PRKG1 | cGMP-dependent protein kinase; phosphorylates targets to reduce calcium sensitivity | Mediates nitric oxide-induced relaxation |
| PRKACA | cAMP-dependent protein kinase A catalytic subunit; promotes relaxation | Central to beta-adrenergic signaling |
| MYLK | Myosin light chain kinase; phosphorylates myosin to promote contraction | Its inhibition is a key step in relaxation |
| PPP1R12A | Myosin light chain phosphatase regulatory subunit; dephosphorylates myosin | Promotes relaxation by reversing MLCK action |
| P2RY1 | Purinergic receptor for ATP; mediates inhibitory neurotransmission | Involved in gastrointestinal relaxation |
| PDGFRA | Receptor for PDGF; marks cells involved in purinergic inhibitory nerve-smooth muscle transmission | Studied in gut motility |
| FAT1 | Cadherin involved in cell migration; may influence smooth muscle phenotype | Linked to vascular smooth muscle cell migration |
| ATP2B1 | Plasma membrane Ca2+ ATPase; extrudes calcium to promote relaxation | Regulates intracellular calcium levels |
| SLC8A1 | Na+/Ca2+ exchanger; contributes to calcium extrusion | Modulates relaxation in vascular smooth muscle |
| RYR2 | Ryanodine receptor; mediates calcium sparks that activate BK channels | Essential for calcium spark generation |
| GUCY1A1 | Guanylyl cyclase alpha subunit; produces cGMP in response to nitric oxide | Mediates NO-induced relaxation |
| NOS3 | Endothelial nitric oxide synthase; produces NO that diffuses to smooth muscle | Key regulator of vascular tone |
| CALD1 | Caldesmon; regulates actin-myosin interaction | Modulates contractility and relaxation |
How Is positive regulation of relaxation of smooth muscle Regulated?
Positive regulation of smooth muscle relaxation is itself regulated at multiple levels. Cyclic nucleotide phosphodiesterases (PDEs) degrade cAMP and cGMP, thereby terminating relaxation signals. Protein phosphatases, such as MLCP, counteract kinases to maintain relaxation. Polyamines can modulate Ca2+ channel and phosphatase activities, influencing the balance between contraction and relaxation. Additionally, calcium sparks and BK channel activity provide a feedback mechanism to limit depolarization and contraction. In disease states, such as after radiotherapy, ATP-mediated relaxation can be reduced, indicating that external factors can dysregulate these pathways.
positive regulation of relaxation of smooth muscle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNMB1 | Hypertension, vascular remodeling | Knockout or knockdown in vascular smooth muscle cells |
| ADRB2 | Asthma, hypertension | Point mutation to alter ligand binding or Gs coupling |
| PDGFRA | Gastrointestinal dysmotility | Knockout in mouse models to study purinergic transmission |
| FAT1 | Vascular smooth muscle migration | Overexpression or knockout in migration assays |
| ATP2B1 | Hypertension | Knock-in of human variants in mice |
Hypertension and Vascular Disease
Impaired positive regulation of smooth muscle relaxation in blood vessels leads to increased vascular tone and hypertension. Reduced expression of KCNMB1, a key regulator of BK channel activity, promotes vascular smooth muscle cell phenotypic switch and apoptosis, contributing to vascular remodeling and disease. Adrenergic signaling, which normally promotes relaxation via beta-adrenergic receptors, can be dysregulated in hypertension. Targeting these pathways is a major therapeutic strategy.
Asthma and Airway Hyperresponsiveness
In asthma, airway smooth muscle fails to relax adequately, leading to bronchoconstriction. Beta-adrenergic agonists, which activate positive regulation of relaxation, are mainstay bronchodilators. Calcium sparks and BK channels also play a role in airway smooth muscle relaxation, and their dysfunction may contribute to hyperresponsiveness.
Gastrointestinal Motility Disorders
Normal gastrointestinal motility depends on coordinated relaxation of smooth muscle. Purinergic inhibitory neurotransmission, involving PDGFRα-positive cells, is critical for this process. Radiotherapy can reduce ATP-mediated relaxation in human rectal smooth muscle, leading to motility dysfunction. Understanding these mechanisms may help treat conditions like irritable bowel syndrome and diabetic gastroparesis.
Urogenital Disorders
Positive regulation of smooth muscle relaxation is essential for erectile function and bladder emptying. While specific citations in this list do not directly address urogenital disorders, the general principles of adrenergic and cyclic nucleotide signaling apply. Dysregulation can lead to erectile dysfunction or overactive bladder.
From positive regulation of relaxation of smooth muscle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KCNMB1 impair smooth muscle relaxation? | KCNMB1 knockout cell line or mouse model |
| How do point mutations in ADRB2 affect relaxation? | Point mutation knock-in via CRISPR in smooth muscle cells |
| Can overexpression of PRKG1 enhance relaxation? | PRKG1 overexpression lentiviral model |
| What is the role of PDGFRα in purinergic relaxation? | PDGFRA knockout mouse or cell line |
| Does FAT1 regulate smooth muscle migration? | FAT1 knockout or overexpression in vascular smooth muscle cells |
| How does radiotherapy affect ATP-mediated relaxation? | Ex vivo human rectal smooth muscle tissue |
How to Study the positive regulation of relaxation of smooth muscle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Tissue bath myography | Force of contraction/relaxation | Testing drugs or gene knockouts on smooth muscle relaxation |
| Calcium imaging | Intracellular Ca2+ levels and sparks | Studying calcium handling in relaxation |
| Patch-clamp electrophysiology | Ion channel activity (e.g., BK channels) | Assessing membrane potential and channel function |
| Western blot | Protein expression and phosphorylation | Detecting signaling changes in relaxation pathways |
| cAMP/cGMP ELISA | Cyclic nucleotide levels | Quantifying second messenger production |
| RNA sequencing | Transcriptome changes | Identifying genes altered in relaxation models |
| CRISPR knockout | Gene function loss | Validating causal roles of candidate genes |
| Proteomics | Protein abundance and modifications | Mapping signaling networks in relaxation |
Functional Contractility Assays
Tissue bath or myograph experiments measure the relaxation response of isolated smooth muscle strips to stimuli such as beta-adrenergic agonists, nitric oxide donors, or purinergic agonists. These assays directly assess positive regulation of relaxation by quantifying changes in force.
Calcium Imaging and Electrophysiology
Fluorescent Ca2+ indicators and patch-clamp electrophysiology are used to measure intracellular Ca2+ transients, calcium sparks, and BK channel activity. These techniques reveal how ion channels and calcium handling contribute to relaxation.
Molecular Signaling Analysis
Western blotting, immunoprecipitation, and kinase activity assays detect phosphorylation events and second messenger levels (cAMP, cGMP). These methods identify which signaling pathways are activated during positive regulation of relaxation.
Genetic and Genomic Approaches
CRISPR-Cas9 knockout, knock-in, and overexpression models, combined with RNA sequencing and proteomics, enable researchers to dissect the causal roles of specific genes in smooth muscle relaxation. These approaches are essential for target validation.
How CRISPR Can Be Used to Study GO:1901082 positive regulation of relaxation of smooth muscle
Knockout
CRISPR knockout of genes such as KCNMB1 or ADRB2 in smooth muscle cell lines or animal models can determine whether they are required for positive regulation of relaxation. For example, KCNMB1 knockout may lead to a synthetic phenotype and impaired relaxation.
Point Mutation
Introducing specific point mutations (e.g., in ADRB2 or KCNMA1) via CRISPR base editing or homology-directed repair allows researchers to study how individual amino acid changes affect receptor signaling or channel gating, thereby modulating relaxation.
Knock-in
Knock-in of reporter tags (e.g., GFP) or human disease variants into endogenous loci enables real-time tracking of protein localization and function in relaxation pathways. This is particularly useful for studying PDGFRα-positive cells in gut motility.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like PRKG1 or ATP2B1 can enhance relaxation and serve as a gain-of-function model to test therapeutic potential.
How EDITGENE Supports positive regulation of relaxation of smooth muscle Research
Researchers studying positive regulation of relaxation of smooth muscle-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in smooth muscle cell models, from knockout to knock-in and overexpression, along with library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of relaxation of smooth muscle research.
Frequently Asked Questions About positive regulation of relaxation of smooth muscle
What is GO:1901082?
GO:1901082 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of relaxation of smooth muscle.
What genes are involved in positive regulation of relaxation of smooth muscle?
Key genes include ADRB2, KCNMA1, KCNMB1, PRKG1, PRKACA, MYLK, PPP1R12A, P2RY1, PDGFRA, and FAT1, among others.
How does beta-adrenergic signaling promote smooth muscle relaxation?
Catecholamines activate beta-adrenergic receptors, increasing cAMP and PKA activity, which reduces calcium sensitivity and promotes relaxation.
What role do BK channels play in smooth muscle relaxation?
BK channels, composed of KCNMA1 and KCNMB1, are activated by calcium sparks and cause membrane hyperpolarization, leading to relaxation.
What diseases are associated with impaired smooth muscle relaxation?
Hypertension, asthma, gastrointestinal dysmotility, and radiotherapy-induced rectal dysfunction are linked to defective relaxation.
How can CRISPR be used to study positive regulation of smooth muscle relaxation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to test the causal role of specific genes in relaxation.
What is the difference between relaxation of smooth muscle and positive regulation of relaxation of smooth muscle?
Relaxation of smooth muscle (GO:0044557) is the process itself, while GO:1901082 covers upstream signals that activate or enhance it.
Which second messengers are involved in smooth muscle relaxation?
cAMP and cGMP are the primary second messengers that activate PKA and PKG to promote relaxation.
How do purinergic nerves regulate smooth muscle relaxation?
Purinergic inhibitory nerves release ATP, which acts on P2Y receptors on PDGFRα-positive cells to facilitate relaxation in the gut.
Can radiotherapy affect smooth muscle relaxation?
Yes, radiotherapy reduces ATP-mediated relaxation in human rectal smooth muscle, indicating that external stressors can impair relaxation pathways.
Conclusion
GO:1901082, positive regulation of relaxation of smooth muscle, is a critical biological process that controls vascular tone, airway diameter, gastrointestinal motility, and urogenital function. The process is orchestrated by a complex interplay of adrenergic receptors, cyclic nucleotides, ion channels, and phosphatases, with key roles for genes such as ADRB2, KCNMA1, KCNMB1, and PRKG1. Dysregulation of these pathways contributes to major human diseases, including hypertension, asthma, and gastrointestinal dysmotility. Understanding the molecular mechanisms and identifying novel regulators through CRISPR-based approaches will pave the way for new therapeutic strategies. EDITGENE offers comprehensive services to support this research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Motiejunaite J et al.. 2021. Adrenergic receptors and cardiovascular effects of catecholamines.. Ann Endocrinol (Paris) 82(3-4):193-197 PMID: 32473788
- 2. Liu H et al.. 2025. Reduced expression of KCNMB1 leads to vascular smooth muscle cell phenotypic switch and apoptosis.. Biochem Pharmacol 241:117151 PMID: 40653026
- 3. Kaneda T et al.. 2003. Lack of cyclic nucleotide regulation of MBCQ-induced relaxation of rat ileal smooth muscle.. J Smooth Muscle Res 39(3):47-54 PMID: 14572172
- 4. Jaggar JH et al.. 2000. Calcium sparks in smooth muscle.. Am J Physiol Cell Physiol 278(2):C235-56 PMID: 10666018
- 5. Huang X et al.. 2020. [Role of platelet-derived growth factor receptor α positive cells in purinergic inhibitory nerve-smooth muscle transmission].. Sheng Li Xue Bao 72(3):391-398 PMID: 32572436
- 6. Nilsson BO et al.. 2002. Regulation of Ca2+ channel and phosphatase activities by polyamines in intestinal and vascular smooth muscle--implications for cellular growth and contractility.. Acta Physiol Scand 176(1):33-41 PMID: 12193217
- 7. Riascos-Bernal DF et al.. 2023. The FAT1 Cadherin Drives Vascular Smooth Muscle Cell Migration.. Cells 12(12) PMID: 37371091
- 8. Kwon YH et al.. 2026. Radiotherapy reduces ATP-mediated relaxation in human rectal smooth muscle.. Am J Physiol Gastrointest Liver Physiol 331(3):G287-G298 PMID: 42538775
